ID26247A - Komposisi farmasi perekat lambung dan/atau usus dua belas jari - Google Patents

Komposisi farmasi perekat lambung dan/atau usus dua belas jari

Info

Publication number
ID26247A
ID26247A IDW20001880A ID20001880A ID26247A ID 26247 A ID26247 A ID 26247A ID W20001880 A IDW20001880 A ID W20001880A ID 20001880 A ID20001880 A ID 20001880A ID 26247 A ID26247 A ID 26247A
Authority
ID
Indonesia
Prior art keywords
gut
adhesive
pharmaceutical composition
twelve fingers
twelve
Prior art date
Application number
IDW20001880A
Other languages
English (en)
Indonesian (id)
Inventor
Toshio Inagi
Hiroyuki Shirai
Takeshi Nishino
Norikazu Yamaguchi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10072099A external-priority patent/JPH11269064A/ja
Application filed by Kowa Co filed Critical Kowa Co
Publication of ID26247A publication Critical patent/ID26247A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
IDW20001880A 1998-03-20 1999-03-17 Komposisi farmasi perekat lambung dan/atau usus dua belas jari ID26247A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10072099A JPH11269064A (ja) 1998-03-20 1998-03-20 胃・十二指腸付着性医薬組成物
JP7209898 1998-03-20

Publications (1)

Publication Number Publication Date
ID26247A true ID26247A (id) 2000-12-07

Family

ID=26413237

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001880A ID26247A (id) 1998-03-20 1999-03-17 Komposisi farmasi perekat lambung dan/atau usus dua belas jari

Country Status (17)

Country Link
US (1) US6582720B1 (no)
EP (1) EP1062955A1 (no)
KR (1) KR20010041019A (no)
CN (1) CN1293576A (no)
AU (1) AU748299B2 (no)
BR (1) BR9908616A (no)
CA (1) CA2320387A1 (no)
EA (1) EA003512B1 (no)
HU (1) HUP0101248A2 (no)
ID (1) ID26247A (no)
MY (1) MY120798A (no)
NO (1) NO20004049L (no)
NZ (1) NZ506280A (no)
PL (1) PL342971A1 (no)
TR (1) TR200002465T2 (no)
TW (1) TW585770B (no)
YU (1) YU51300A (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4980527B2 (ja) * 1999-06-07 2012-07-18 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸に不安定な活性化合物を含有する新規の製剤および投与形
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
MXPA04009968A (es) 2002-04-09 2004-12-13 Flamel Tech Sa Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s).
DE60323474D1 (de) 2002-04-09 2008-10-23 Flamel Tech Sa Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US20050281795A1 (en) * 2004-06-17 2005-12-22 Amano Enzyme Usa., Ltd. And Amano Enzyme,Inc. Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
US8252333B2 (en) 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
US20080279921A1 (en) * 2007-05-07 2008-11-13 Ceramoptec Industries, Inc. Gel-formulations of hydrophobic photosensitizers for mucosal applications
US8303573B2 (en) 2007-10-17 2012-11-06 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090105561A1 (en) * 2007-10-17 2009-04-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US8707964B2 (en) * 2007-10-31 2014-04-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8789536B2 (en) 2007-10-17 2014-07-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8808276B2 (en) * 2007-10-23 2014-08-19 The Invention Science Fund I, Llc Adaptive dispensation in a digestive tract
US8808271B2 (en) * 2007-10-31 2014-08-19 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090163894A1 (en) * 2007-10-31 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US8109920B2 (en) * 2007-10-31 2012-02-07 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8333754B2 (en) * 2007-10-31 2012-12-18 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090137866A1 (en) * 2007-11-28 2009-05-28 Searete Llc, A Limited Liability Corporation Of The State Delaware Medical or veterinary digestive tract utilization systems and methods
EP2255794A1 (en) * 2009-05-29 2010-12-01 H e x a l Aktiengesellschaft Enteric coating
EP2480250B1 (en) 2009-09-24 2014-04-16 Allergan, Inc. Compositions comprising botulinum toxin A or B for use in the treatment of osteoporosis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE4036757A1 (de) * 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
TW209174B (no) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
ES2145102T3 (es) 1993-09-09 2000-07-01 Takeda Chemical Industries Ltd Formulacion que comprende una sustancia antibacteriana y una sustancia antiulcerosa.
AU685262B2 (en) * 1994-03-30 1998-01-15 Gs Development Ab Use of fatty acid esters as bioadhesive substances
JPH09104640A (ja) 1995-08-04 1997-04-22 Takeda Chem Ind Ltd 胃粘膜付着性組成物
EP0867191A4 (en) * 1995-11-27 2000-01-05 Yamanouchi Pharma Co Ltd MEDICINE COMPOSITION
JPH10167985A (ja) 1996-10-08 1998-06-23 Takeda Chem Ind Ltd 抗ヘリコバクター剤
CN1251035A (zh) 1997-03-25 2000-04-19 武田药品工业株式会社 胃肠粘膜粘附性药物组合物

Also Published As

Publication number Publication date
EA200000973A1 (ru) 2001-02-26
EA003512B1 (ru) 2003-06-26
TR200002465T2 (tr) 2000-12-21
KR20010041019A (ko) 2001-05-15
NZ506280A (en) 2001-08-31
MY120798A (en) 2005-11-30
CA2320387A1 (en) 1999-09-30
NO20004049D0 (no) 2000-08-11
YU51300A (sh) 2002-09-19
HUP0101248A2 (hu) 2001-08-28
EP1062955A1 (en) 2000-12-27
AU2852499A (en) 1999-10-18
US6582720B1 (en) 2003-06-24
AU748299B2 (en) 2002-05-30
TW585770B (en) 2004-05-01
CN1293576A (zh) 2001-05-02
NO20004049L (no) 2000-10-03
PL342971A1 (en) 2001-07-16
BR9908616A (pt) 2000-10-31

Similar Documents

Publication Publication Date Title
FI973447A7 (fi) Sulkimen ja injektioruiskun yhdistelmä
DE69709366D1 (de) Medizinische klebende zusammensetzung und verpackung
BR9800344A (pt) Composição de vidro e utilização das composições de vidro
IL136252A0 (en) Pharmaceutical and diagnostic compositions containing ab or fragments thereof
DE69609616D1 (de) Initiatorsystem und daraus hergestellte klebstoffzusammensetzung
FI973039A0 (fi) Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
FI973279A7 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
DE69910186D1 (de) Pharmazeutische zusammensetzung von topiramate
FI973475L (fi) Koostumus ja sitä sisältävä tuote
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
BR9609831A (pt) Composições cosméticas e/ou farmacêuticas antipruríticas
ID28548A (id) Azalida-azalida beranggota-13 dan penggunaannya sebagai bahan-bahan antibiotik
ID24828A (id) Komposisi-komposisi farmasi dari tizoksianida dan nitazoksanida
FI965204A7 (fi) Bromelaiinin lääkekäyttö
FI971711L (fi) Levobupivakaiinin ja sen analogien kiteyttäminen
EE04870B1 (et) Tisoksaniidi ja nitasoksaniidi farmatseutilised kompositsioonid
BR9907100B1 (pt) pentassacarídeos, composição farmacêutica compreendendo os mesmos e utilização dos ditos pentassacarídeos
FI971427L (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
BR9607757A (pt) Vírus recombinante defectivo adenovírus utilização de um vírus e composição farmacêutica
EE03806B1 (et) Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid
NO994542D0 (no) Organisering av datamaskinbuffer
BR9709964A (pt) Derivados de catecol aplicação de derivados de catecol e medicamento
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
FI963263L (fi) Bromelaiinin lääkinnällinen käyttö
ID22378A (id) Komposisi untuk mencegah dan mengobati penyakit gusi